Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...
Moderna's new version of its COVID-19 vaccine, which targets two virus variants including Omicron, has outperformed the company's original Spikevax shot in a head-to-head clinical trial.
Moderna has been ordered to pay almost £44,000 after 12-year-olds were encouraged to join Covid vaccine trials with the ...
Moderna has asked the FDA for emergency use authorisation for a fourth dose of its mRNA COVID-19 vaccine SpikeVax ... Pfizer's application was from an open-label study in Israel involving ...
This includes more than $3.0 billion in Spikevax ... label extension study. The Company began generating registrational trial data in 2024. Methylmalonic acidemia (MMA) therapeutic: Moderna's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results